Home/Curavac/Dr. Jean-Paul Prieels, Ph.D.

DJ

Dr. Jean-Paul Prieels, Ph.D.

Chief Scientific Officer

Therapeutic Areas

Autoimmune Diseases

Curavac Pipeline

Drug	Indication	Phase
CV-MG02	Myasthenia Gravis (MG)	Phase 2

Leadership Team at Curavac

Dr. Stéphane Huberty

Founder and Chief Executive Officer

Nicolas Havelange

Chief Operating Officer

Matthieu André

Chief Financial Officer

Dimitri F. Dimitriou

Executive Chairman of the Board

View full Curavac profile